比亞迪AH股逆勢上漲 正式發佈刀片電池且宣佈進入量產階段
格隆匯3月30日丨比亞迪AH股今日分別逆勢上漲3.6%和2.7%。比亞迪昨天舉行刀片電池發佈會,首次對外公佈了“刀片電池”順利通過“針刺試驗”的完整測試視頻;同時,還宣佈刀片電池已經進入量產階段,將搭載在比亞迪C級高端轎車“漢”車型上,預計今年6月份在深圳投產上市。刀片電池最大的特點是通過結構創新,在成組時跳過“模組”,大幅提高體積利用率,即在有限的汽車空間內安裝更多的電池,從而在續航里程上媲美三元鋰電池,而其高安全、高壽命、低成本等優勢,是當前三元鋰電池所不具備的。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.